Literature DB >> 22914993

Focusing on patient needs and preferences may improve genetic counseling for colorectal cancer.

Simone Salemink1, Nicky Dekker, Carolien M Kets, Erica van der Looij, Wendy A G van Zelst-Stams, Nicoline Hoogerbrugge.   

Abstract

During cancer genetic counseling, different items which counselors consider important are discussed. However, relatively little empirical evidence exists regarding the needs and preferences of counselees. In this study needs and preferences were assessed from counselees with a personal and/or family history of colorectal cancer (CRC), who were referred for genetic counseling regarding CRC. They received a slightly modified version of the QUOTE-GENE(ca) questionnaire prior to their first visit to the Hereditary Cancer Clinic. Response rate was 60 % (48/80 participants). Counselees rated the importance of 45 items assessing their needs and preferences regarding the content and process of genetic counseling. Participants rated the items regarding discussion of information about their familial CRC risk (100 %) and preventive options (98 %) as important or very important. Fewer participants rated items concerning general information on genetics as important. Sensitive communication during counseling was considered very important by a large percentage of counselees. Generally, no major differences were seen between participants in relation to individual characteristics. Our data suggest that focusing on familial CRC risk and surveillance options, in combination with sensitive communication may lead to better satisfaction with genetic counseling.

Entities:  

Mesh:

Year:  2012        PMID: 22914993      PMCID: PMC3553404          DOI: 10.1007/s10897-012-9519-5

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


Introduction

The lifetime risk of developing colorectal cancer (CRC) in Western society is approximately 5–6 % (Jemal et al. 2009; The Netherlands Cancer Registry). The majority of these patients have sporadic CRC, while familial and hereditary cancers account for approximately 15 % to 20 % of all CRCs (de Jong and Vasen 2006; Grover et al. 2004; Lynch and de la Chapelle 2003). In these families, healthy relatives of CRC patients have an increased risk of developing CRC themselves, which may be prevented by surveillance colonoscopies (Dove-Edwin et al. 2005; Jarvinen et al. 2000). Familial CRC risk is generally divided into three groups, based on cumulative lifetime risks of developing CRC (Dutch Society for Clinical Genetics 2008): Average—familial CRC risk below 10 % Moderate—familial CRC risk of 10–15 % High—familial CRC risk above 15 % For patients with a high familial CRC risk, referral for genetic counseling is recommended. During genetic counseling, patients and their relatives receive information on the consequences and nature of hereditary CRC, the most common being Lynch syndrome. In a subset of families, genetic analysis for Lynch syndrome is performed by microsatellite instability (MSI) and/or DNA-testing. Based on these test results and the interpreted family history, a tailored surveillance plan is proposed by the clinical geneticist or genetic counselor. Regular surveillance by colonoscopy is crucial for individuals with an increased familial CRC risk, as it can reduce CRC-related morbidity and mortality up to 80 % (Dove-Edwin et al. 2005; Jarvinen et al. 2000). Currently, most at-risk individuals for CRC have not had a surveillance colonoscopy (Longacre et al. 2006). Amongst other reasons, one underlying cause seems to be the inadequate recognition of individuals at risk for CRC. To improve this aspect of healthcare, a new Dutch guideline on familial and hereditary CRC was introduced in 2008, in which clinicians have new tasks in calculating, interpreting, and communicating familial CRC risk (Dutch Society for Clinical Genetics 2008). These tasks should lead to better recognition of individuals at an increased familial CRC risk, enabling them to undergo surveillance colonoscopies. Family history, the basis of clinical indication, does not predict by itself whether an individual undergoes CRC surveillance or not (Griffith et al. 2008). Therefore, there must be other barriers for at-risk individuals to undergo surveillance. Some of these barriers might even be related to socio-demographic factors, such as age (Bleiker et al. 2005) or education level (Halbert et al. 2004). However, several studies showed that recommendation for CRC screening by a healthcare provider is a significant predictor of timely screening for individuals at increased risk for CRC (Griffith et al. 2008; Lewis et al. 2006). Interventions also seem to be most successful when recommendations are tailored to individuals or communities (Powe et al. 2010). From this perspective, tailoring genetic counseling to the needs and preferences of the counselee may lead to better understanding of the importance of CRC screening and thus increase surveillance uptake. The traditional model for cancer genetic counseling focuses on the systematic discussion of cancer genetics, medical facts, risks of developing cancer, psychosocial consequences, and surveillance policy. This model is based on general key goals of genetic counseling regarding hereditary cancer as previously established by the counselors: (a) identifying individual needs and concerns of the counselee, (b) providing information on genes and chromosomes, (c) giving an individual risk assessment in the context of supportive interaction, and (d) discussing the pros and cons of genetic testing and drawing up a surveillance plan (Lobb et al. 2001). During counseling, careful attention must also be given to the patient’s autonomy and ability to make well-informed decisions regarding testing and adoption of preventive strategies (Robson et al. 2010; Lobb et al. 2002). Counselors’ main goals of genetic counseling for hereditary CRC are well known; however, to our knowledge, the needs and preferences of counselees have scarcely been assessed. Previous studies investigated women’s preferences for the genetic counseling aspects of providing cancer, gene, and risk information (information); giving advice about cancer surveillance (surveillance); preparing for genetic testing (preparation); and assistance with decision-making (direction). The researchers found that women who were offered BRCA1/2 testing had the highest preference for getting information and lowest preference for direction (Apicella et al. 2005; Peacock et al. 2006). Counselees may also need information about the genetic counseling procedure prior to a first counseling visit (Pieterse et al. 2005b). Yet, in order to provide optimal tailoring of genetic counseling for hereditary CRC, further investigation of specific needs and preferences of the counselee and their relation to socio-demographic factors is required. Knowing what patients need and prefer enables the counselor to tailor information on a surveillance plan as much as possible. Such a personalized recommendation for CRC screening by a healthcare provider may increase the probability that those individuals at risk for CRC will undergo timely surveillance. This exploratory pilot study was performed to answer the following research questions: 1) During genetic counseling, which counseling items and communication strategies are important to counselees suspected of hereditary CRC? and 2) Are counselees’ preferences related to their individual characteristics such as medical history, genetic counseling history, gender, and age?

Methods

Participants

Counselees referred to the Hereditary Cancer Clinic of the Radboud University Nijmegen Medical Centre, the Netherlands, between May 2010 and July 2010 for genetic counseling on hereditary colorectal cancer (CRC) were eligible for this study. Inclusion criteria were (a) referral for genetic counseling for familial CRC or Lynch syndrome, and (b) age 18 years and above. Counselors included both clinical geneticists and genetic counselors. Due to ethical reasons, no data were collected from non-participants.

Procedures

To evaluate counselees’ requirements concerning genetic counseling in case of hereditary cancer, an instrument called QUOTE-geneca was developed by Pieterse et al. (Pieterse et al. 2005a). In the current study, counselees received a standard invitation to the Hereditary Cancer Clinic, as well as a pre-visit anonymous questionnaire based on QUOTE-geneca. Counselees were asked to return the questionnaire within 1 week. Clinical records were consulted to determine the medical status of the participant (affected or unaffected with CRC) and whether the counselee was the first in the family seeking genetic advice (index patient) or sought presymptomatic testing (in case of a known mutation in the family). Mutation carriers were offered surveillance by regular colonoscopies. Non-carriers (true negatives, being patients in whom a known family mutation is not found) were told that undergoing surveillance was unnecessary. If there was no known family mutation and no mutation was found in the patient, either no surveillance plan or a less intensive surveillance plan was drawn up according to national guidelines for familial CRC, based on family history.

Questionnaire

The first part of the pre-visit questionnaire assessed gender, age, education level and nationality. The main part of the questionnaire was based on the QUOTE-geneca questionnaire (Pieterse et al. 2005a), which in turn is derived from the QUOTE scale (‘Quality of Care Through the Patients’ Eyes’) (Sixma et al. 2000). The QUOTE-geneca questionnaire intends to measure needs and preferences in genetic counseling for hereditary cancer. This questionnaire has been shown to capture relevant issues of concern with a high internal consistency, and is associated with previously validated measures of coping style and distress (Pieterse et al. 2005a). Some items were rephrased, without changing the content of each item. For example, the item “my risk or the risk for my family” was split into two separate items: “my own risk” and “the risk for my family.” Also, an item about “the option of additional support by a social worker” was added. As these are minor changes, we expect the psychometric properties of our questionnaire to be comparable to the original QUOTE-geneca questionnaire. The questionnaire contained a list of cancer-specific items and a list of generic items. Cancer-specific items included “own risk of developing cancer,” “determination and meaning of being a carrier of a cancer gene,” “emotional aspects for counselee and family,” and “heredity of cancer in general.” Generic items included “procedural aspects of counseling,” “sensitive communication,” “emotional support,” and “assessment of susceptibility to the disease.” Counselees rated the importance of each item using a four-point, Likert-type scale (1 = not important, 2 = fairly important, 3 = important, 4 = extremely important). For data analysis, ratings 1 and 2 were merged to “(not or fairly) important” and ratings 3 and 4 to “(very) important.”

Data Analysis

The interrelations between patients’ needs and preferences and their individual characteristics were compared using cross tabs and the Fisher’s Exact test. Individual characteristics used in the statistical analyses were: gender (men versus women), age (<35 years versus aged 35–50 years, versus >50 years), medical status (affected with CRC versus unaffected with CRC), education (low versus middle versus high) and medical background (medical background versus no medical background). Education levels were subdivided into “low” (primary school), “middle” (junior and senior secondary vocational education), and “high” (higher vocational education and university education). All computations were done with the SPSS statistical package (release 16.0). Two-sided p-values below 0.05 were considered to be statistically significant.

Results

Forty-eight of 80 counselees (60 %) participated in this study. Table 1 shows the baseline characteristics of these 48 participants. There were 22 men (46 %) and 26 women (54 %). Their mean age upon completion of the questionnaire was 51.6 years (SD = 11.3; Range: 19–72).
Table 1

Participant baseline characteristics (n = 48)

n a %
Age (years)
 Mean (s.d.)51.6 (11.3)
 Range19–72
Gender
 Men2246
 Women2654
Kind of referral
 First in family seeking advice (index)4083
 Presymptomatic715
Personal medical history
 Participant affected with CRC1531
 Participant unaffected with CRC3369
Educationb
 Low1531
 Middle2042
 High1225
Social status
 Living together (cohabitation, married)3981
 Living alone (single, widow, divorced)919
Medical background
 No4083
 Yes715
Nationality
 Dutch4696
 Other24

aSample sizes vary due to missing data; bLow = primary school; Middle = junior and senior secondary vocational education; High = higher vocational education and university education

Participant baseline characteristics (n = 48) aSample sizes vary due to missing data; bLow = primary school; Middle = junior and senior secondary vocational education; High = higher vocational education and university education

Needs and Preferences Prior to the First Visit

As shown in Table 2, counselor provision of information about the counselee’s own risk of developing (a second) CRC, as well as this risk for relatives, was rated as important by every participant (100 %). Almost every participant wanted to know what to do if they had an increased risk of developing CRC (98 %). Counselor explanation of emotional consequences for themselves and for their family were rated as (very) important by 70 % and 81 % of participants, respectively. Fewer participants considered the items about heredity of cancer in general as (very) important, e.g. the prevalence of cancer in the Netherlands (35 %).
Table 2

Frequencies of counselees’ ratings of cancer-specific needs and preferences as important or very important (n = 48)a

During counseling, the counselor should explain…(Very) important
n %
How risks for myself and my family are computed4696
 Own risk of developing cancer
  My risk of developing cancer (again)48100
  What to do if I have an increased risk of cancer4698
  What to do if I do not have an increased risk of cancer3677
 Determination and meaning of being a carrier of a cancer gene
  Whether the cancer in my family is hereditary4594
  Why I am/am not considered for further examination4494
  What it means to be a carrier of a certain gene4390
  Possibilities of DNA-testing4390
  What it means to be a carrier of a cancer gene4390
  Limitations of DNA-testing4185
  The procedure of DNA-testing3981
 Emotional aspects for counselee and family
  My family members’ risk of developing cancer (again)47100
  What it means not to be a carrier of a cancer gene4083
  Emotional consequences for my family as a result of genetic counseling3881
  The procedure of studying the family history3574
  Emotional consequences for myself as a result of genetic counseling3370
 Heredity of cancer in general
  How cancer is inherited in a family4185
  How often cancer is hereditary3471
  Background information (chromosomes, DNA, genes)3471
  The prevalence of cancer in the Netherlands1735

aSample sizes vary due to missing data

Frequencies of counselees’ ratings of cancer-specific needs and preferences as important or very important (n = 48)a aSample sizes vary due to missing data With regard to generic items of genetic counseling, all participants considered it (very) important that the counselor takes them seriously, listens carefully, gives enough time and attention, involves them in decisions that are made, and provides clear and understandable explanations (100 %). These items represent sensitive communication during genetic counseling; every item in this category was rated as (very) important by all or almost every participant. Fewer participants considered discussion by the counselor of the option of additional support by a social worker (44 %), communication with family members (60 %), and talking about the emotional aspects of the diagnostic procedure (65 %) as (very) important. These items represent emotional support during genetic counseling (see Table 3).
Table 3

Frequencies of counselees’ ratings of generic needs and preferences as important or very important (n = 48)a

During counseling, the counselor should…(Very) important
n %
Provide me with clear and understandable explanations48100
 Sensitive communication
  Take me seriously48100
  Listen carefully48100
  Give me enough time and attention48100
  Involve me in the decisions that are made48100
  Be skilled4798
  Give advice4798
  Give me the opportunity to ask questions4798
  Be open to my wishes, values and my opinions4390
 Procedural aspects of counseling
  Give medical information4696
  Explain the procedure of genetic counseling4696
  Be punctual with appointments4594
  Inform me sufficiently about what to expect4492
  Cooperate well with my other doctors, e.g. GP or specialist4492
  Give the opportunity to ask questions at any time4492
  Explain the roles of the providers4288
  Tell me how much time the diagnostic procedure takes3267
 Assessment of susceptibility to disease
  Tell me what the risk for my family is4696
  Tell me what my risk is4494
  Carry out a DNA-test on me or a family member3981
  Analyze the family history3881
 Emotional support
  Provide me (also) with written information4390
  Reassure me3677
  Show understanding and sympathy3675
  Talk about the emotional aspects of the diagnostic procedure3165
  Discuss communication with family members2860
  Discuss the option of additional support by a social worker2144

aSample sizes vary due to missing data

Frequencies of counselees’ ratings of generic needs and preferences as important or very important (n = 48)a aSample sizes vary due to missing data

Items Involving Cancer-Specific Topics

Unaffected participants were more likely to consider receiving information about the procedure of studying the family history (very) important compared to participants affected with cancer, p = 0.025. In other words, a greater percentage of healthy participants wanted to know how a genetic risk assessment is made compared to affected patients (85 % vs. 50 %, respectively). As reported previously, receiving an explanation about their own risk of developing cancer or developing cancer again was rated as (very) important by all participants. Thus, no major differences due to participants’ background variables were seen for this item. No other significant relationships were obtained for participant characteristics and their ratings of the cancer-specific questionnaire items.

Differences on Generic Items Due to Participants’ Individual Characteristics

Sensitive communication was (very) important for almost all participants and was not significantly related to their individual characteristics. However, women more often than men rated the item ‘the counselor is open to their wishes, values and opinions’ as (very) important, p = 0.015 (100 % vs. 77 %, respectively). No other significant differences on general items were seen as a function of participants’ individual characteristics.

Discussion

Major Findings

The results of this study show that the most prevalent information topics perceived as important by counselees prior to their first genetic counseling session are their familial colorectal cancer risk and surveillance options. Additionally, sensitive communication during genetic counseling is considered of extreme importance by counselees. Fewer counselees considered emotional aspects and general information on genetics as important. Ratings of the importance of needs and preferences generally did not differ significantly between the different socio-demographic groups.

The Meaning and Importance of These Findings

Sensitive communication during counseling was considered very important as well by a large percentage of counselees. Especially, counselees consider it very important that the counselor takes him or her seriously, listens carefully, gives enough time and attention, and involves him or her in the decisions that are made. Evidently, the interaction between counselor and counselee is viewed as fundamental for successful counseling. This was also seen in a study by Veach et al. (2007), who published the results of a consensus meeting among genetic counselors and other healthcare professionals, in which they describe a reciprocal-engagement model of genetic counseling practice including goals and strategies that can be used during the genetic counseling process. Our results can be used to adapt future genetic counseling on hereditary CRC to the needs and preferences of the counselee. By better adapting the genetic counseling to the needs and preferences of the counselee, consultation time can be saved and used to explain important and complex issues instead, such as familial CRC risk and surveillance options for those who are at risk for CRC. The focus of genetic counseling must be on topics considered important and less on topics not considered essential by both counselor and counselee. By adapting genetic counseling to counselees’ preferences, counseling may become more effective and more attention can be given to surveillance options for those who warrant surveillance. Although generally no significant differences in needs and preferences were found in relation to counselees’ socio-demographic characteristics, it is important to keep in mind that every counselee has specific needs and preferences based on other factors. Besides, this study showed that sensitive communication was considered very important by every counselee. Counselors should take into account what might explain observed trends in different needs and preferences. For example, presymptomatic counselees may consider emotional aspects during genetic counseling more important than patients who are the first members of a family seeking advice on hereditary CRC. These so-called index patients may not always foresee possible outcomes. In addition, in this study, healthy participants were more likely to consider it important to understand the process of genetic risk assessment compared to affected participants. It is possible that participants with CRC consider risk assessment less important because they were affected already with CRC. Also, the present findings suggest women consider it more important than men that the counselor is open to their wishes, values, and opinions. One explanation could be that men have more interest in facts and medical information, while women consider communication itself more important. In consideration of these interpersonal differences, counselors always need to verify a counselee’s personal background and adapt their counseling to their individual situation.

Relation of the Findings to Those of Similar Studies

The results of our study are partly in line with findings from other research. Peacock et al. (2006) showed that women’s preferences include information and surveillance advice. Our study distinguishes between medical information (see Table 3) and background information (see Table 2) and shows that especially medical information is considered (very) important by 96 % of the counselees. The need for background information on chromosomes, DNA, and genes is considered (very) important by 71 % of the counselees. Our results also concur with previous findings by Pieterse et al. (Pieterse et al. 2005a). In their study, 200 new counselees, primarily counseled for breast and colon cancer, completed a QUOTE-geneca questionnaire prior to their first consultation. They found that the patients’ preferences when interacting with the counselor were receiving information, risk and preventive strategies for oneself and/or family members and information about the procedure of genetic counseling. Less patients considered emotional support and discussing emotional aspects as very important beforehand. However, 91 % of the counselees in that study were women. This leads to difficulties with extrapolation of these findings to genetic counseling for late-onset diseases that men and women seek more equally, such as CRC. Although the power of our study was limited, no major significant differences in needs and preferences between men and women were found. This indicates that this instrument can be meaningfully adapted to counselees for other types of late-onset hereditary cancers. In another study by Pieterse et al., 130 counselees, referred mainly for breast or colon cancer, completed a questionnaire containing the QUOTE-geneca before their first appointment at a genetic clinic (Pieterse et al. 2005b). They showed that counselees had a stronger psychosocial focus than counselors, as counselees initiated the discussion of emotional consequences of DNA testing more often than their counselor, compared to other topics assessed. However, our study shows that counselees seeking presymptomatic testing consider emotional aspects of genetic counseling more important than those who are the first in the family seeking genetic advice. Providing more information on the counseling content and procedure prior to their visit may prepare counselees for possible unforeseen consequences of genetic counseling. Furthermore, new counselees may be advised to prepare for the visit more thoroughly, allowing them to verbalize questions more frequently during consultation (Albada et al. 2011; Pieterse et al. 2005b).

Study Limitations

The results of our study are based on a limited number of counselees from one country. In addition, 40 % of the eligible participants did not enroll in this study, possibly limiting generalizability of the results. Since no data were collected for the non-participants, the possibility of an enrollment bias cannot be excluded. However, a strength of our study is that the group of participating counselees was very diverse, for instance in age, being affected with cancer or not, education, and gender. Another limitation to consider is that, by asking preselected questions, participants get an idea of possible items being addressed during genetic counseling. The fact that these items are proposed in the questionnaire, implies that they are at least important to someone else. This may be the reason that some participants were inclined to score all topics as (very) important, which may cause a social desirability bias. Also, a four point scale without a mid-point appears to push more respondents towards the positive end of the scale (Worcester and Burns 1975). In addition, educational level may have influenced counselees’ understanding of the questionnaire items. However, the percentage of low educated participants is normal compared to the general population and almost all questions were answered in which no differences were seen among counselees with different education levels, suggesting that this was not the case.

Practice Implications and Research Recommendations

The results of our study may contribute to optimal adaptation of genetic counseling for hereditary colorectal cancer to counselees’ needs. Focusing on familial CRC risk and surveillance options may lead to better satisfaction with genetic counseling and improved adherence to surveillance policies. However, it remains important for all counselors to keep in mind that every counselee has their own specific needs and preferences. Since there is great variability among counselees, using a questionnaire such as the QUOTE-geneca prior to the first genetic counseling session may help genetic counselors to determine which items to discuss with the counselee. However, it is necessary to explore the best content and format as well as assess the added value of this strategy. Additionally, larger studies are needed to determine whether indeed, very few differences in needs and preferences are present between counselees with different socio-demographics. It will also be necessary to explore whether patient satisfaction and surveillance uptake for colorectal cancer can indeed be improved in this manner.
  22 in total

Review 1.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

Review 2.  A review of intervention studies that seek to increase colorectal cancer screening among African-Americans.

Authors:  Barbara D Powe; Rachel Faulkenberry; Lokie Harmond
Journal:  Am J Health Promot       Date:  2010 Nov-Dec

3.  The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands.

Authors:  A E de Jong; H F A Vasen
Journal:  Neth J Med       Date:  2006-11       Impact factor: 1.422

4.  Use and evaluation of an individually tailored website for counselees prior to breast cancer genetic counseling.

Authors:  Akke Albada; Margreet G E M Ausems; Roel Otten; Jozien M Bensing; Sandra van Dulmen
Journal:  J Cancer Educ       Date:  2011-12       Impact factor: 2.037

5.  Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: a pilot study.

Authors:  E A Lobb; P N Butow; A Moore; A Barratt; K Tucker; C Gaff; J Kirk; T Dudding; D Butt
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

6.  Quality of care from the perspective of elderly people: the QUOTE-elderly instrument.

Authors:  H J Sixma; C van Campen; J J Kerssens; L Peters
Journal:  Age Ageing       Date:  2000-03       Impact factor: 10.668

7.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

8.  Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.

Authors:  Shilpa Grover; Elena M Stoffel; Laoti Bussone; Elizabeth Tschoegl; Sapna Syngal
Journal:  Clin Gastroenterol Hepatol       Date:  2004-09       Impact factor: 11.382

9.  Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.

Authors:  Chanita Hughes Halbert; Henry Lynch; Jane Lynch; David Main; Susan Kucharski; Anil K Rustgi; Caryn Lerman
Journal:  Arch Intern Med       Date:  2004-09-27

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  9 in total

1.  Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need.

Authors:  Soo Jung Hong; Barbara Biesecker; Jennifer Ivanovich; Melody Goodman; Kimberly A Kaphingst
Journal:  J Genet Couns       Date:  2019-01-24       Impact factor: 2.537

2.  Personalized genomic results: analysis of informational needs.

Authors:  Tara J Schmidlen; Lisa Wawak; Rachel Kasper; J Felipe García-España; Michael F Christman; Erynn S Gordon
Journal:  J Genet Couns       Date:  2014-02-03       Impact factor: 2.537

3.  The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users.

Authors:  Shachar Zuckerman; Sigal Gooldin; David A Zeevi; Gheona Altarescu
Journal:  J Assist Reprod Genet       Date:  2020-05-27       Impact factor: 3.412

4.  Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.

Authors:  Aisha S Sie; Judith B Prins; Liesbeth Spruijt; C Marleen Kets; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

5.  More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.

Authors:  Aisha S Sie; Wendy A G van Zelst-Stams; Liesbeth Spruijt; Arjen R Mensenkamp; Marjolijn J L Ligtenberg; Han G Brunner; Judith B Prins; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

6.  Development of an integrated support system for hereditary cancer and its impact on gynecologic services.

Authors:  Mina Morii-Kashima; Hiroshi Tsubamoto; Chika Sato; Mariko Ushioda; Naohiro Tomita; Yasuo Miyoshi; Tomoko Hashimoto-Tamaoki; Kazuo Tamura; Hideaki Sawai; Hiroaki Shibahara
Journal:  Int J Clin Oncol       Date:  2013-12-19       Impact factor: 3.402

7.  Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.

Authors:  Georgina L Fenton; Amelia K Smit; Lucinda Freeman; Caro Badcock; Kate Dunlop; Phyllis N Butow; Judy Kirk; Anne E Cust
Journal:  J Genet Couns       Date:  2017-12-03       Impact factor: 2.537

8.  High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.

Authors:  Aisha S Sie; Liesbeth Spruijt; Wendy A G van Zelst-Stams; Arjen R Mensenkamp; Marjolijn J L Ligtenberg; Han G Brunner; Judith B Prins; Nicoline Hoogerbrugge
Journal:  J Genet Couns       Date:  2015-11-04       Impact factor: 2.537

Review 9.  Finding all BRCA pathogenic mutation carriers: best practice models.

Authors:  Nicoline Hoogerbrugge; Marjolijn Cj Jongmans
Journal:  Eur J Hum Genet       Date:  2016-09       Impact factor: 4.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.